GGrantIndex
Sort

17,828 grants matching crispr

Epigenetic & Genomics

$197,525
Sven W Heinz · University Of California, San Diego · P30 · FY2021 · DK

Defining the disorders of genome organization

$197,518
Philip Michael Boone · Massachusetts General Hospital · K08 · FY2021 · NS

Defining the disorders of genome organization

$197,518
Philip Michael Boone · Massachusetts General Hospital · K08 · FY2020 · NS

CAREER: High bandwidth nano-transistors to understand the kinetic basis for CRISPR/CAS enzymes to enhance their applications for diagnostics and therapeutics

$197,503
Kiana Aran · University Of California-San Diego · · FY2023 · ENG

Nicotinic receptor gene editing vectors

$197,500
Ryan Michael Drenan · Northwestern University At Chicago · R21 · FY2017 · DA

The relationship between spike response and calcium fluorescent signal in insect olfactory receptor neurons

$197,500
Chih-Ying Su · University Of California, San Diego · R21 · FY2022 · AI

Development of precision genome editing tools in Ae. albopictus for functional genetics and mosquito control technologies

$197,500
Omar Sultan Akbari · University Of California, San Diego · R21 · FY2022 · AI

Host-directed Therapeutics for Amebiasis

$197,500
Chelsea S. Marie · University Of Virginia · R21 · FY2017 · AI

Rescue of Cul3 haploinsufficiency phenotypes with CRISPR-mediated Cul3 activation

$197,500
Lilia M Iakoucheva · University Of California, San Diego · R21 · FY2023 · MH

Elucidating the regulation and function of IL-17D using reporter mice

$197,292
Jack D Bui · University Of California, San Diego · R21 · FY2021 · AI

Transgenic Animal Shared Facility

$197,286
Robert A Kesterson · University Of Alabama At Birmingham · P30 · FY2020 · CA

CRISPR/Cas9 guided production of genetically engineered pigs lacking CD8+ T-cells

$197,225
Kiho Lee · Virginia Polytechnic Inst And St Univ · R21 · FY2015 · OD

Human Genetics and Microbiome Core

$197,217
Mark J Daly · Massachusetts General Hospital · P30 · FY2022 · DK

Human Genetics and Microbiome Core

$197,217
Mark J Daly · Massachusetts General Hospital · P30 · FY2023 · DK

Human Genetics and Microbiome Core

$197,217
Mark J Daly · Massachusetts General Hospital · P30 · FY2025 · DK

Human Genetics and Microbiome Core

$197,217
Mark J Daly · Massachusetts General Hospital · P30 · FY2024 · DK

CRL3KEAP1 complex licenses genotoxic stress-induced tumor cell death

$197,189
Yi-Nan Gong · University Of Pittsburgh At Pittsburgh · R21 · FY2022 · CA

Developing CRISPR genome editing technology for Entamoeba

$197,125
Upinder Singh · Stanford University · R21 · FY2021 · AI

High-throughput discovery of novel transcriptional programs regulating T cell exhaustion

$197,119
Weiguo Cui · Northwestern University At Chicago · R21 · FY2025 · AI

Innate Immunity of Zika Virus Infection In Human Neural Progenitors

$197,100
Caleb Stokes · University Of Washington · K08 · FY2020 · AI

Core 4 Sali Echeverria

$196,979
Andrej Sali · University Of California, San Francisco · U54 · FY2023 · AI

The ODC A allele as a driver and therapeutic target of aggressive prostate cancer in African American men

$196,934
Jong Y Park · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2022 · CA

High-throughput identification of novel therapeutic targets in lung cancer from genes with altered mRNA splicing

$196,899
Angela Norie Brooks · University Of California Santa Cruz · R21 · FY2019 · CA

Regulation of Cell Death and Inflammation by ISG15 during SARS-CoV2 Infection

$196,875
Deborah J Lenschow · Washington University · R21 · FY2021 · AI

Development of CRISPR-Cas9 gene drive technology in mice with potential for broad utility and applied genetics

$196,875
Kimberly L Cooper · University Of California, San Diego · R21 · FY2019 · GM